PMID: 18215773

Pissarra LS, Farinha CM, Xu Z, Schmidt A, Thibodeau PH, Cai Z, Thomas PJ, Sheppard DN, Amaral MD
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
Chem Biol. 2008 Jan;15(1):62-9., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:5:135
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:5:120
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:5:141
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:5:126
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:5:147
status: NEW
view ABCC7 p.Gln637Arg details
Although F508del-NBD1 shows only minor conformational changes relative to that of wild-type NBD1, additional mutations (F494N/Q637R or F429S/F494N/Q637R) were required for domain solubility and crystallization. Login to comment
23 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 18215773:23:125
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:23:118
status: NEW
view ABCC7 p.Gly550Glu details
ABCC7 p.Arg555Lys
X
ABCC7 p.Arg555Lys 18215773:23:136
status: NEW
view ABCC7 p.Arg555Lys details
Some of these mutations represented sequence changes between human CFTR and CFTRs from other species, whereas others (G550E, R553Q, and R555K) had been previously identified as F508del-CFTR revertant mutations (Teem et al., 1996; deCarvalho et al., 2002; Chang et al., 1999). Login to comment
25 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 18215773:25:34
status: NEW
view ABCC7 p.Arg553Gln details
Of note, one of these revertants, R553Q, was found in an F508del-homozygous patient with mild CF disease (Do¨ rk et al., 1991). Login to comment
26 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:26:41
status: NEW
view ABCC7 p.Gly550Glu details
In addition, another revertant mutation, G550E, likely acts by altering the structure of NBD1 (Roxo-Rosa et al., 2006). Login to comment
33 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:33:140
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:33:78
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:33:146
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:33:84
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:33:153
status: NEW
view ABCC7 p.Gln637Arg details
However, these new F508del-NBD1 crystal structures still required either two (F494N/Q637R; Protein Data Bank [PDB] ID code: 2BBT) or three (F429S/F494N/ Q637R; PDB ID code: 2BBS) additional mutations for domain solubility and, hence, crystal formation (Lewis, 2005). Login to comment
35 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:35:82
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:35:66
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:35:88
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:35:72
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:35:94
status: NEW
view ABCC7 p.Gln637Arg details
To test these ideas, we investigated the effects of the mutations F494N/Q637R and F429S/F494N/Q637R on wt- and F508del-CFTR by studying: (1) the in vivo folding yield of NBD1, (2) the processing and trafficking of the full-length CFTR protein, and (3) the ClÀ channel function of CFTR. Login to comment
37 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:37:149
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:37:120
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:37:155
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:37:127
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:37:161
status: NEW
view ABCC7 p.Gln637Arg details
RESULTS While studying the effects of F508del on the structure of NBD1 from CFTR, Lewis (2005) introduced the mutations F494N/ Q637R (double; D) and F429S/F494N/Q637R (triple; T) into NBD1 to improve domain solubility and crystallization. Login to comment
42 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:42:75
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:42:77
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:42:82
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:42:84
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:42:93
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:42:95
status: NEW
view ABCC7 p.Gln637Arg details
Solubilizing Mutations Improve wt- and F508del-NBD1 Yield To explore whether F429S, F494N, and Q637R improve the yield of soluble NBD1, wt-NBD1 and F508del-NBD1 were expressed in bacterial cells in the absence and presence of the solubilizing mutations. Login to comment
144 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:144:120
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:144:99
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:144:126
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:144:105
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:144:132
status: NEW
view ABCC7 p.Gln637Arg details
Structural Implications An interesting aspect of the action of the solubilizing mutations (double, F494N/Q637R; triple, F429S/F494N/Q637R) is their remote location from that of F508. Login to comment
146 ABCC7 p.Phe508Arg
X
ABCC7 p.Phe508Arg 18215773:146:142
status: NEW
view ABCC7 p.Phe508Arg details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:146:32
status: NEW
view ABCC7 p.Phe494Asn details
However, the effect produced by F494N is not completely unexpected, as structural crosstalk between the side chain of the F508 residue (e.g., F508R) and the Q loop or g-phosphate switch (e.g., residues W496 and M498) has been previously shown to occur (Massiah et al., 1999). Login to comment
148 ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:148:11
status: NEW
view ABCC7 p.Gln637Arg details
Curiously, Q637R lies in this helix, known as the RD1 region (residues 590-672) of NBD1. Login to comment
151 ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:151:109
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:151:50
status: NEW
view ABCC7 p.Gln637Arg details
In support of this notion, our data indicate that Q637R, at least with one additional solubilizing mutation (F494N), might contribute to the increased solubility of F508del-NBD1 and to the partial rescue of F508del-CFTR trafficking and function. Login to comment
152 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:152:33
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:152:161
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:152:109
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:152:167
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:152:115
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:152:173
status: NEW
view ABCC7 p.Gln637Arg details
The third solubilizing mutation, F429S, further promotes the revertant effect produced by the double mutant (F494N/Q637R) on F508del-CFTR, as the triple mutant (F429S/F494N/Q637R) visibly increased maturation of F508del-CFTR as measured by the higher maturation yield at steady state of F508delT-CFTR compared with that of F508delD-CFTR (Figure 1C). Login to comment
154 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:154:19
status: NEW
view ABCC7 p.Phe429Ser details
This suggests that F429S might lie on the surface of NBD1 in a position where it likely interacts with the environment (Lewis et al., 2004, 2005). Login to comment
155 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:155:199
status: NEW
view ABCC7 p.Gly550Glu details
ABCC7 p.Arg555Lys
X
ABCC7 p.Arg555Lys 18215773:155:297
status: NEW
view ABCC7 p.Arg555Lys details
ABCC7 p.Arg516Lys
X
ABCC7 p.Arg516Lys 18215773:155:290
status: NEW
view ABCC7 p.Arg516Lys details
ABCC7 p.Arg29Lys
X
ABCC7 p.Arg29Lys 18215773:155:284
status: NEW
view ABCC7 p.Arg29Lys details
ABCC7 p.Arg766Lys
X
ABCC7 p.Arg766Lys 18215773:155:308
status: NEW
view ABCC7 p.Arg766Lys details
Comparison with Other Revertants Using the same cellular system employed to investigate the solubilizing mutations, we recently examined the mechanism of action of two other F508del-CFTR revertants, G550E and 4RK, the simultaneous mutation of four arginine-framed tripeptides (AFTs), R29K, R516K, R555K, and R766K (Roxo-Rosa et al., 2006). Login to comment
157 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:157:0
status: NEW
view ABCC7 p.Gly550Glu details
G550E likely alters the conformation of NBD1, whereas 4RK allows F508del-CFTR to escape endoplasmic reticulum retention/retrieval mediated by AFTs. Login to comment
158 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:158:25
status: NEW
view ABCC7 p.Gly550Glu details
We also showed that both G550E and 4RK affected wt-CFTR (Roxo-Rosa et al., 2006). Login to comment
160 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:160:41
status: NEW
view ABCC7 p.Gly550Glu details
ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:160:310
status: NEW
view ABCC7 p.Gly550Glu details
Moreover, whereas the revertants 4RK and G550E restored the iodide efflux of F508del-CFTR to wt levels (Roxo-Rosa et al., 2006), the magnitude of iodide efflux elicited by F508delD- and F508delT-CFTR was less than that of wt-CFTR. This indicates that the solubilizing mutations are not as effective as 4RK and G550E at augmenting either the cell-surface expression or function of F508del-CFTR. Login to comment
161 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:161:95
status: NEW
view ABCC7 p.Gly550Glu details
However, at steady state, F508delD and F508delT produced amounts of band C similar to those of G550E- or 4RK-F508del (present study and A.S. and M.D.A., unpublished data). Login to comment
165 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:165:87
status: NEW
view ABCC7 p.Gly550Glu details
By contrast, both revertant mutations markedly prolonged the MBD of F508del-CFTR, with G550E exceeding that of wt-CFTR by 4-fold (Roxo-Rosa et al., 2006). Login to comment
166 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:166:15
status: NEW
view ABCC7 p.Gly550Glu details
Moreover, only G550E suppressed the prolonged IBI of F508del-CFTR (Roxo-Rosa et al., 2006), reducing it to a level similar to that achieved here with F508delT-CFTR. Login to comment
167 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:167:179
status: NEW
view ABCC7 p.Gly550Glu details
We interpret these data to suggest that the conformation state(s) that solubilizing mutations achieve is closer to that of wt-CFTR than the conformation produced by the revertant G550E (Roxo-Rosa et al., 2006). Login to comment
168 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:168:64
status: NEW
view ABCC7 p.Gly550Glu details
Consistent with this interpretation, the revertants, especially G550E, extended the MBD and elevated the Po of wt-CFTR (Roxo-Rosa et al., 2006), whereas wt-CFTR containing the solubilizing mutations had the same MBD, IBI, and Po as wt-CFTR. Login to comment
169 ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 18215773:169:97
status: NEW
view ABCC7 p.Gly550Glu details
We thus suggest that the solubilizing mutations act specifically on F508del-CFTR (in contrast to G550E) to abrogate its gating defect, possibly through correction of NBD1 and/or CFTR folding. Login to comment
175 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:175:126
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:175:111
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:175:133
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:175:117
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:175:139
status: NEW
view ABCC7 p.Gln637Arg details
The available crystal structure of F508del-NBD1 was determined after the introduction of additional mutations (F494N/Q637R or F429S/ F494N/Q637R) to help domain solubilization and crystal formation. Login to comment
182 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:182:110
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:182:210
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:182:212
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:182:94
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:182:116
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:182:261
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:182:263
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:182:100
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:182:123
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:182:312
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:182:314
status: NEW
view ABCC7 p.Gln637Arg details
Site-Directed Mutagenesis, Cells, and CFTR Expression To introduce the solubilizing mutations F494N/Q637R and F429S/F494N/ Q637R into wt- and F508del-CFTR cDNAs in the pNUT expression vector, we used the primers F429S, 50 -GGTGATGACAGCCTCTCCTTCAGTAATTTC TCA-30 ; F494N, 50 -CATTCTGTTCTCAGAATTCCTGGATTATGCCTGG-30 ; Q637R, 50 -GAACTCCAAAATCTAAGGCCAGACTTTAGCTC-30 and the QuikChange site-directed mutagenesis kit (Stratagene). Login to comment
187 ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:187:163
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe429Ser
X
ABCC7 p.Phe429Ser 18215773:187:206
status: NEW
view ABCC7 p.Phe429Ser details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:187:93
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:187:126
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:187:169
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Phe494Asn
X
ABCC7 p.Phe494Asn 18215773:187:212
status: NEW
view ABCC7 p.Phe494Asn details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:187:99
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:187:141
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:187:175
status: NEW
view ABCC7 p.Gln637Arg details
ABCC7 p.Gln637Arg
X
ABCC7 p.Gln637Arg 18215773:187:226
status: NEW
view ABCC7 p.Gln637Arg details
Cell lines expressing different solubilizing mutations are referred to as follows: wtD-CFTR, F494N-Q637R-CFTR; F508delD-CFTR, F494N- F508del-Q637R-CFTR; wtT-CFTR, F429S-F494N-Q637R-CFTR; and F508delT-CFTR, F429S-F494N-F508del-Q637R-CFTR. Login to comment